GenoBioTX develops advanced genetically engineered animal models, offering 15,000+ catalog strains, 1,000+ humanized models along with 19,000+ custom models for drug discovery. GenoBioTX also provides pre-clinical CRO and fully human antibody development services across multiple disease areas, with a focus on immuno-oncology. For more information, visit genobiotx.com.